Prof. Dr. Dr. Fred Harms
Head of Institute for Preventive Medicine and Health Services Research, Sigmund Freud Private University, Vienna
Prof. Dr. Dr. Fred Harms
Head of Institute for Preventive Medicine and Health Services Research, Sigmund Freud Private University, Vienna
KLOUD
Scientific Advocate
In addition to his numerous professional activities and memberships, Prof. Dr. Dr. Fred Harms is a strong supporter of KLOUD and an integral part of the CENTROPIX Science Board.
Prof. Dr. Dr. Fred Harms studied biochemistry and medicine from 1986 to 1996 at the University of Witten/Herdecke, the University of Münster, the M.D. Anderson Cancer Center, Houston, Texas, USA and the University of Bangkok, graduating with an MD/PhD in tumor immunology/oncology. From 1997 to 1999, he was a lecturer in Innovation Management in Life Sciences at the Technical University of Darmstadt, Germany, and from 2000 to 2004, he was a lecturer in Health Care Management at the Technical University of Berlin, Germany.

From 2005 to 2007, he was a lecturer in Health Care Business Management at the University of Hamburg. From 2008 to 2009, he was Scientific Director for Pharmaceutical Business Management at the Center for Healthcare Management at the University of Krems and Chairman of the Center from 2010 to 2012. He taught as a Professor of Healthcare Management at the Mayes College of Healthcare Business and Policy at the University of Philadelphia, USA. Since 2013, he has headed the Institute for Preventive Medicine and Health Services Research together with Prof. Dr. Dorothee Gänshirt at Sigmund Freud Private University Vienna. The Institute works in cooperation with various European health institutions on developing strategies for prevention, compliance, and disease management of chronic diseases and evaluating potential benefits of medical innovations for patient care. In addition to his university activities, he was Director Oncology and Global Project Manager at Merck KGaA in Darmstadt respectively at Imclone NY, USA, from 1996 to 2002. He was responsible for developing Erbitux, a chimeric monoclonal antibody for treating colorectal cancer. From 2002 to 2003 he was Vice President of OncoScore (Novartis-Venture Basel) and Consultant of the Tumor Bank of the University Hospital Basel, and from 2004 to 2014 member of the Executive Board of the Health Care Competence Center (HC3) in Basel and since 2016 founder and member of the Executive Board of Beneganic Organic Vitamins in Zurich. Since 2020, he has been a member of the Executive Board of Beneganic AG in Pfäffikon SZ. In 2020, Beneganic AG was awarded the Innovation Award 2020/2021 as Top Innovator and Award Winner – Future made in Switzerland for its research in the field of nutraceuticals. In 2019, Prof. Harms was accredited as a psycho-oncologist after training by the Institute for Psycho-Oncological Training Cologne in cooperation with the German Cancer Society.

Fred Harms is the author of about 220 publications, book chapters, and lectures at scientific congresses.
In addition to his numerous professional activities and memberships, Prof. Dr. Dr. Fred Harms is a strong supporter of KLOUD and an integral part of the CENTROPIX Science Board.
Prof. Dr. Dr. Fred Harms studied biochemistry and medicine from 1986 to 1996 at the University of Witten/Herdecke, the University of Münster, the M.D. Anderson Cancer Center, Houston, Texas, USA and the University of Bangkok, graduating with an MD/PhD in tumor immunology/oncology. From 1997 to 1999, he was a lecturer in Innovation Management in Life Sciences at the Technical University of Darmstadt, Germany, and from 2000 to 2004, he was a lecturer in Health Care Management at the Technical University of Berlin, Germany.

From 2005 to 2007, he was a lecturer in Health Care Business Management at the University of Hamburg. From 2008 to 2009, he was Scientific Director for Pharmaceutical Business Management at the Center for Healthcare Management at the University of Krems and Chairman of the Center from 2010 to 2012. He taught as a Professor of Healthcare Management at the Mayes College of Healthcare Business and Policy at the University of Philadelphia, USA. Since 2013, he has headed the Institute for Preventive Medicine and Health Services Research together with Prof. Dr. Dorothee Gänshirt at Sigmund Freud Private University Vienna. The Institute works in cooperation with various European health institutions on developing strategies for prevention, compliance, and disease management of chronic diseases and evaluating potential benefits of medical innovations for patient care.

In addition to his university activities, he was Director Oncology and Global Project Manager at Merck KGaA in Darmstadt respectively at Imclone NY, USA, from 1996 to 2002. He was responsible for developing Erbitux, a chimeric monoclonal antibody for treating colorectal cancer. From 2002 to 2003 he was Vice President of OncoScore (Novartis-Venture Basel) and Consultant of the Tumor Bank of the University Hospital Basel, and from 2004 to 2014 member of the Executive Board of the Health Care Competence Center (HC3) in Basel and since 2016 founder and member of the Executive Board of Beneganic Organic Vitamins in Zurich. Since 2020, he has been a member of the Executive Board of Beneganic AG in Pfäffikon SZ. In 2020, Beneganic AG was awarded the Innovation Award 2020/2021 as Top Innovator and Award Winner – Future made in Switzerland for its research in the field of nutraceuticals. In 2019, Prof. Harms was accredited as a psycho-oncologist after training by the Institute for Psycho-Oncological Training Cologne in cooperation with the German Cancer Society.

Fred Harms is the author of about 220 publications, book chapters, and lectures at scientific congresses.
International Memberships

Since 1994

New York Academy of Sciences
Since 1995
American Association for the Advancement of Science
2001 – 2005

Member of High-Technology Post-Graduate-Programs in Europe (EXIST)

Since 2003
American Society for Marketing and Management Advances
2005 – 2015

Vice President of European Health Care Foundation

Since 2006
Member of the Board of the International Prevention Organization (IPO Brussels)
2012 – 2014

Member of the Scientific Advisory Board of Roche AG (Diabetology Division)

International Memberships

Since 1994

New York Academy of Sciences
Since 1995
American Association for the Advancement of Science
2001 – 2005

Member of High-Technology Post-Graduate-Programs in Europe (EXIST)

Since 2003
American Society for Marketing and Management Advances
2005 – 2015

Vice President of European Health Care Foundation

Since 2006
Member of the Board of the International Prevention Organization (IPO Brussels)
2012 – 2014

Member of the Scientific Advisory Board of Roche AG (Diabetology Division)

Honors and Awards
1997 – 1991
Scholarship holder of the program for high potentials in life sciences of Hoechst AG Frankfurt
1992 – 1994

Scholarship holder of the Chemical Industry Study Fund of Henkel AG Düsseldorf

2005 – 2006
Merck, Sharp & Dohme Foundation Research Fellow, Whitehouse Station, NJ
Honors and Awards
1997 – 1991
Scholarship holder of the program for high potentials in life sciences of Hoechst AG Frankfurt
1992 – 1994

Scholarship holder of the Chemical Industry Study Fund of Henkel AG Düsseldorf

2005 – 2006
Merck, Sharp & Dohme Foundation Research Fellow, Whitehouse Station, NJ
More Scientists

Please fill out the form and a 

CENTROPIX representative will 

contact you about our products.

[wpforms id="1690" title="false"]

George Gasich

Co-Founder & Co-CEO of CENTROPIX LLC

George has been a direct selling titan for 30 years and helped revolutionize the network marketing industry.

After graduating from Indiana University, George discovered direct sales and quickly made a career as a senior sales rep at Fund America, Quorum, Quantum Leap, Melaleuca, Immune-26, Enagic.

Youcef Benloucif

Co-Founder & Co-CEO of CENTROPIX LLC

With three decades of experience as an elite salesperson, holistic health professional, and global entrepreneur, Youcef’s successes have influenced and empowered hundreds of thousands of lives. He founded Holistic Solutions Technologies and co-founded the Tobias Healing Institute, a functioning orthomolecular medical practice. He also achieved the highest rank in terms of sales, group sales, and earned a position as a certified academy director and advisor to one of the largest PEMF companies on the planet. Youcef works tirelessly to promote the “natural healing of the body.”

Nik Gleim

Co-Founder & CEO of CENTROPIX Global AG

Nik Gleim is an expert in the field of P.E.M.F. technology with over twenty-five years of experience. He started his professional career in Munich in 1996, selling computer hardware and software and carrying out network installations.

In 1999, Gleim founded his first production round of P.E.M.F. products. More than 25 years down the road he became an Expert in creating new products from scratch and bringing them successfully into the worldwide market. “Playing the piano on each key” is what makes his profession complete.

Chris Klinsky

Co-Founder & Head of Marketing at CENTROPIX Global AG

Chris Klinsky is responsible for building and training a global network of CENTROPIX sales partners. He’s an experienced sales manager with over 20 years of professional experience in managing, leading, and training global teams of up to 11’000 salespeople. He started his career as a sales manager in various real estate, insurance, and finance companies before gaining a foothold in the wellness and health industry. Chris was also the managing co-owner of a large investment consulting firm for nine years and the managing partner of a coaching and training company for sales for over six years and knows exactly what it takes to build an international, strong sales team.